The Rockford IceHogs announced Tuesday that the BMO Center will feature new state-of-the-art digital dasher boards, set to ...

Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

Novo Nordisk shares jumped 10% today after the US Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival Eli Lilly in the fast-evolving ...

Nike stock (NKE) is sliding in Friday's trading session after the athletic apparel titan's fiscal second quarter release that beat earnings and revenue estimates. While Wall Street continues to appear ...

Sadiq Adatia, CIO at BMO Asset Management, joins BNN Bloomberg to discuss the upcoming headwinds for the markets in 2026.

In this episode of the Wine and Gold Talk podcast, Ethan Sands and Jimmy Watkins are joined by The Athletic’s Joel Lorenzi ...

Dividend stocks (which commonly are value stocks, but can be growth stocks) are great ways to drive long-term performance of ...

From a chart analysis perspective, Adobe is entrenched in a confirmed downtrend. The $400 level now acts as a key resistance point, while the shares struggle to maintain support around $355. A ...

The partnership with Runway, announced on December 18, designates Adobe as a preferred API partner. This grants the software giant exclusive early access to Runway's models, starting with Gen-4.5, for ...

Evan Seigerman, managing director and head of healthcare research at BMO Capital Markets, joins BNN Bloomberg to discuss the FDA's approval of Wegovy weight loss pill from Novo Nordisk.

In a significant strategic shift, Amazon is centralizing its artificial intelligence operations under a single leadership ...

Evan Seigerman, BMO head of healthcare research, joins 'Power Lunch' to discuss Seigerman's thoughts on Novo Nordisk, its ...